Edwards Lifesciences Corp
SWB:EWL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Edwards Lifesciences Corp
SWB:EWL
|
US |
|
B
|
BRP Inc
F:B15A
|
CA |
|
Planet Fitness Inc
NYSE:PLNT
|
US |
|
D
|
Deutsche Bank AG
SWB:DBK
|
DE |
|
Novartis AG
NYSE:NVS
|
CH |
|
AST SpaceMobile Inc
NASDAQ:ASTS
|
US |
|
V
|
Vita 34 AG
DUS:V3V
|
DE |
|
N
|
Noah Holdings Ltd
HKEX:6686
|
CN |
|
Plazza AG
SIX:PLAN
|
CH |
|
Almirall SA
MAD:ALM
|
ES |
|
S
|
Starbucks Corp
SWB:SRB
|
US |
|
Warner Bros Discovery Inc
F:J5A
|
US |
|
E
|
Eagle Bancorp Montana Inc
F:8F5
|
US |
|
N
|
NTT Data Corp
F:NT5
|
JP |
|
S
|
Southern Co
XHAM:SOT
|
US |
|
M
|
Modine Manufacturing Co
F:MMF
|
US |
|
A
|
Alibaba Group Holding Ltd
F:2RR
|
CN |
|
M
|
Mitsubishi Electric Corp
F:MIE1
|
JP |
|
J
|
JD.Com Inc
XBER:013C
|
CN |
|
Rivian Automotive Inc
NASDAQ:RIVN
|
US |
|
BHP Group Ltd
LSE:BHP
|
AU |
Wall St Price Targets
EWL Price Targets Summary
Edwards Lifesciences Corp
According to Wall Street analysts, the average 1-year price target for EWL is 85.69 EUR with a low forecast of 75.12 EUR and a high forecast of 101.06 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EWL's stock price target?
Price Target
85.69
EUR
According to Wall Street analysts, the average 1-year price target for EWL is 85.69 EUR with a low forecast of 75.12 EUR and a high forecast of 101.06 EUR.
What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 10%.
What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.
What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.
What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 20%.
